Bone Solutions Inc. Reaches 50 Implants Of Its Proprietary Magnesium-Based Bone Void Filler

Share Article

“This milestone is a huge accomplishment for our company, and we’re excited to continue to introduce our product to surgeons around the country,” says BSI president and CEO Drew Diaz.

Bone Solutions Inc. (BSI), an orthobiologics technology company located in Colleyville, TX, is proud to announce it has reached 50 successful implants of OsteoCrete®, its magnesium-based orthopedic medical device. OsteoCrete®, which was launched in September 2017, is a bone void filler designed to assist with bone repair and generation. It’s the first in the U.S. to incorporate magnesium, a critical property for bone health and development.

“This milestone is a huge accomplishment for our company, and we’re excited to continue to introduce our product to surgeons around the country,” says BSI president and CEO Drew Diaz.

The OsteoCrete® implants were performed by various surgeons in the U.S. during BSI’s 90-day launch period, which ran from October 1 to December 31, 2017. The company worked with a network of distributors to deliver and implement the product. BSI will now shift its focus to attaining approvals at various hospital systems in the U.S.

OsteoCrete® is the only bone-repair product in the market made with magnesium. This gives surgeons an advantage as compared to using calcium-based devices, which do not have the unique combination of compressive strength and expandability necessary for optimal binding quality. OsteoCrete® is resorbable, or capable of being assimilated back into the body, as it is replaced with bone as the patient heals. It’s also injectable, moldable, and biocompatible.

“I am confident 2018 will be a banner year for the company, and we look forward to the continued growth of both the market and the use of OsteoCrete® in future surgical applications,” says Diaz.

About Bone Solutions Inc.
Bone Solutions Inc. (‘BSI’) (http://www.bonesolutionsinc.com) is an orthobiologics company with a vision to provide orthopedic surgeons a means to improve clinical outcomes in a number of complex procedures while lowering costs. The company is revolutionizing a new solution for orthopedic surgeons for human uses with their FDA-cleared magnesium-based platform bone void filler.

Media Contact:

Bone Solutions Inc.:
Drew Diaz
President/CEO
817-809-8850
diaz(at)bonesolutions(dot)net

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Drew Diaz
BSI
+1 817-307-4848
Email >
Visit website